Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03005106 · ClinicalTrials.gov registry record · Phase 3
StrataGraft® Skin Tissue in the Promotion of Autologous Skin Regeneration of Complex Skin Defects Due to Thermal Burns That Contain Intact Dermal Elements
A Phase 3 study of Burn, Thermal, sponsored by Stratatech, a Mallinckrodt Company.
- Completed
- Registry status
- Phase 3
- Development phase
- 71
- Enrollment target
- 16
- Study locations
NCT03005106 is a Phase 3 study of Burn, Thermal that has completed, run by Stratatech, a Mallinckrodt Company. The registered enrollment target is 71 participants. The trial reports 16 study locations across 13 states.
The verdict
NCT03005106, a Phase 3 study of Burn, Thermal, has completed, sponsored by Stratatech, a Mallinckrodt Company.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 71 participants
- Enrollment target
- 16
- Study locations
Study Summary
About 70 participants will be enrolled. They will have complex skin defects because of burns caused by heat. The burns will: * be on 3-49% of the participant's total body surface area (TBSA) * require surgery for skin replacement * include intact dermal elements The burns are called deep, partial-thickness thermal burns because the skin was damaged by heat but still has some dermis that was not damaged. The dermis is the layer of skin under the outer layer (epidermis). It is the thickest layer of the skin that provides strength and flexibility to the skin. All patients will receive both treatments, but on different areas of their burns. Their wounds will not be compared to other patients. One treatment area on their own body will be compared to the other one. This will help to find out if StrataGraft is safe and effective for deep partial thickness burns. It will also see if StrataGraft might help healing enough to use it instead of the patient's own healthy skin to repair the damage.
Conditions Studied
Interventions
- BIOLOGICAL StrataGraft Skin Tissue
- PROCEDURE Autograft
Study Locations (16)
California
- Universtiy of California - Irvine Health Regional Burn Center - Orange
- UC Davis - Sacramento
Florida
- University of Florida Health Shands Burn Center - Gainesville
- Tampa General Hospital - Regional Burn Center - Tampa
Louisiana
- Baton Rouge Medical Center - Baton Rouge
- University Medical Center - New Orleans
Alabama
- University of South Alabama Medical Center - Mobile
Arizona
- Arizona Burn Center at Maricopa Medical Center - Phoenix
District of Columbia
- MedStar Washington Hospital Center - Washington D.C.
Iowa
- University of Iowa - Iowa City
Missouri
- University of Missouri - Columbia
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 71 participants |
| Start Date | 2017-05-30 |
| Est. Completion | 2020-03-27 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03005106
The ClinicalTrials.gov registry entry for NCT03005106 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 71 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Stratatech, a Mallinckrodt Company, which has 9 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Burn, Thermal appearing as the primary indexed condition, and to 2 interventions - of which StrataGraft Skin Tissue is the first listed.
NCT03005106 reports 16 study locations spanning 13 distinct geographic areas - top geographies include California, Florida, Louisiana.
Frequently Asked Questions
What is clinical trial NCT03005106 about?
NCT03005106 is a clinical study titled "StrataGraft® Skin Tissue in the Promotion of Autologous Skin Regeneration of Complex Skin Defects Due to Thermal Burns That Contain Intact Dermal Elements". About 70 participants will be enrolled. They will have complex skin defects because of burns caused by heat. The burns will: * be on 3-49% of the participant's total body surface area (TBSA) * require surgery for skin replacement * include intact dermal elements The burns are called deep, partial...
What is the current status of trial NCT03005106?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 71 participants. The study started on 2017-05-30. Estimated completion is 2020-03-27.
What conditions does trial NCT03005106 study?
This clinical trial studies the following conditions: Burn, Thermal.
What interventions are being tested in trial NCT03005106?
The interventions under investigation include: StrataGraft Skin Tissue (BIOLOGICAL), Autograft (PROCEDURE).
Who is sponsoring clinical trial NCT03005106?
This trial is sponsored by Stratatech, a Mallinckrodt Company, which has 9 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03005106 being conducted?
This trial has 16 study locations across Alabama, Arizona, California, District of Columbia, Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.